Latest news
This Mumbai drugmaker is investing ₹700 crore in its fastest-growing business - CNBC TV18CNBC TV18 · Fri, 31 Jul 2026 07:00:00 GMTRPG LIFE SCIENCES API ARM TO RAISE ₹243CR FROM INVASCENT, BUY ACTIS GENERICS FOR ₹80CR - ICICI DirectICICI Direct · Fri, 31 Jul 2026 05:04:49 GMTRPG Life Sciences spins off API arm, brings in PE firm InvAscent on board - Moneycontrol.comMoneycontrol.com · Thu, 30 Jul 2026 07:00:00 GMT